Bioheng Competitors and Similar CompaniesClear all

Bioheng's competitors and similar companies include Aptus Clinical, OmniSeq, IO Biosciences and Hubro Therapeutics.
Bioheng
Bioheng
Bioheng (also known as Nanjing Beiheng Biotech, 北恒生物) is a biopharmaceutical company that focuses on immunotherapy and gene therapy for treating cancer.
Aptus Clinical
Aptus Clinical
Aptus Clinical is a clinical contract research organization that specializes in oncology, rare diseases, and cell and gene therapies.
OmniSeq
OmniSeq
OmniSeq is a company that provides molecular diagnostic laboratory services.
IO Biosciences
IO Biosciences
IO Biosciences is a company focused on developing allogeneic, gene-modified cell therapies treating cancers.
Hubro Therapeutics
Hubro Therapeutics
Hubro Therapeutics is a company that develops proprietary neo-peptide technology platforms and immunotherapies for the treatment of cancer.
Founding Date
Founding Date
2017
Founding Date
2014
Founding Date
2015
Founding Date
2017
Founding Date
2018
Type
Type
Private
Type
Private
Type
Subsidiary
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Nanjing, CN HQ
Locations
Alderley Edge, GB HQ
Locations
Buffalo, US HQ
Locations
Doylestown, US HQ
Locations
Oslo, NO HQ
Employees
Employees
N/A
Employees
26
Employees
26
Employees
N/A
Employees
3

Funding

Total funding raised
Total funding raised
$ 94.8m
Total funding raised
N/A
Total funding raised
$ 11.6m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Aptus Clinical
HQ
Alderley Edge, GB
Employees
26

Aptus Clinical is a clinical contract research organization that specializes in oncology, rare diseases, and cell and gene therapies.

View company
OmniSeq
HQ
Buffalo, US

OmniSeq is a company that provides molecular diagnostic laboratory services.

View company
IO Biosciences
HQ
Doylestown, US

IO Biosciences is a company focused on developing allogeneic, gene-modified cell therapies treating cancers.

View company
Hubro Therapeutics
HQ
Oslo, NO

Hubro Therapeutics is a company that develops proprietary neo-peptide technology platforms and immunotherapies for the treatment of cancer.

View company